匯納科技(300609.SZ):控股股東變更爲金石一號、實控人變更爲江澤星
格隆匯8月5日丨匯納科技(300609.SZ)公佈,公司於2025年8月5日收到上海金石一號智能科技合夥企業(有限合夥)(以下簡稱“金石一號”)與上海寶金石一號智能科技合夥企業(有限合夥)(以下簡稱“寶金石一號”)的通知,金石一號、寶金石一號分別通過協議轉讓方式受讓張宏俊先生持有的12,011,412股、6,005,720股公司股份(分別佔公司總股本的10.00%和5.00%)的事項已取得深圳證券交易所出具確認意見,並已在中國證券登記結算有限責任公司辦理完成過戶登記手續,取得了《證券過戶登記確認書》。至此,公司控股股東變更爲金石一號,公司實際控制人變更爲江澤星先生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.